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Abstract
The trophectoderm (TE) is the first epithelium to be generated during mammalian early development. The TE works as a barrier that isolates the
inner cell mass from the uterine environment and provides the turgidity of the blastocyst through elevated hydrostatic pressure. In this study, we
investigated the role of tight junctions (TJs) in the barrier function of the TE during mouse blastocyst formation. RT-PCR and immunostaining
revealed that the mouse TE expressed at least claudin 4, 6, and 7 among the 24 members of the claudin gene family, which encode structural and
functional constituents of TJs. When embryos were cultured in the presence of a GST-fused C-terminal half of Clostridium perfringens enterotoxin
(GST-C-CPE), a polypeptide with inhibitory activity to claudin 4 and 6, normal blastocyst formation was remarkably inhibited; the embryos had no
or an immature blastocoel cavity without expansion, and blastomeres showed a rounded shape. In these embryos, claudin 4 and 6 proteins were
absent from TJs and the barrier function of the TE was disrupted; however the basolateral localization of the Na+/K+-ATPase α1 subunit and
aquaporin 3, which are thought to be involved in blastocyst formation, appeared normal. These results clearly demonstrate that the barrier function
of TJs in the TE is required for normal blastocyst formation.
© 2007 Elsevier Inc. All rights reserved.Keywords: Tight junctions; Claudin; Blastocyst; TrophectodermIntroduction
The epithelium plays fundamental roles in the architecture of
metazoans. It primarily separates the body environment from its
external environment. In the body, epithelial structures are
involved in the establishment and maintenance of distinct fluid
compartments, which are required for development as well as
for the physiological functions of various organs. To accom-
plish these functions, epithelial cellular sheets not only
selectively transport substances via transporter proteins within
the plasma membrane, but also work as barriers to separate
these compartments.☆ This paper is dedicated to the memory of the late Shoichiro Tsukita.
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doi:10.1016/j.ydbio.2007.09.049The first epithelial structure that emerges during mamma-
lian early development is the trophectoderm (TE) epithelium,
which covers the surface of the blastocyst and encloses the
inner cell mass (ICM). Mouse TE differentiation begins at the
morula stage of an 8-cell embryo when strong intercellular
adhesion (compaction) by E-cadherin occurs accompanied by
cell polarization (Shirayoshi et al., 1983; Vestweber and
Kemler, 1984). Then, by the 32-cell stage during blastocyst
formation, the outer blastomeres acquire complete epithelial
characteristics to form the TE, which encloses the ICM and
generates the blastocoel cavity by vectorial transport of ions,
water, and other small molecules (reviewed by Fleming et al.,
2001; Biggers et al., 1988; Watson et al., 2004). In the
blastocyst, the blastocoel cavity is filled with blastocoelic
fluid, providing the ICM with a unique environment separated
from the outer uterine environment.
To date, several membrane transporters that are expressed in
the TE have been demonstrated to be essential molecular
510 K. Moriwaki et al. / Developmental Biology 312 (2007) 509–522mechanisms for blastocyst formation. Na+ transport by the TE
in a TE-to-blastocoel direction establishes ionic gradients across
the TE, leading to the accumulation of fluid within the
blastocoel cavity and providing the turgidity of the blastocyst
owing to the elevated hydrostatic pressure. The trans-TE ionic
gradient formation appears to be driven by Na+/K+-ATPases
located within the basolateral membrane domains of the TE
(reviewed by Biggers et al., 1988; Kidder, 2002; Watson et al.,
2004). When Na+/K+-ATPase activity is blocked by ouabain, a
specific inhibitor of this enzyme, normal blastocyst formation is
blocked in vitro (Biggers et al., 1978). Further evidence
indicating the involvement of Na+/K+-ATPases in this process
is the finding that blastocyst expansion is retarded in the
absence of extracellular Na+ (Manejwala et al., 1989). Multiple
isoforms of alpha- and beta-subunits of Na+/K+-ATPase are
expressed in murine preimplantation embryos, and they appear
to show functional redundancy (MacPhee et al., 2000; Barcroft
et al., 2004). In the apical membrane domain, the NHE-3 Na+/
H+-exchanger (Kawagishi et al., 2004), Na+/glucose (Wiley et
al., 1991), and Na+/amino acid cotransporter (DiZio and Tasca,
1977), as well as amiloride-sensitive Na+ channels (Powers et
al., 1977), seem to participate in the uptake of Na+ into the TE to
support the activity of Na+/K+-ATPases.
Another important membrane transporter involved in blas-
tocyst formation is the aquaporin water channel (Barcroft et al.,
2003). Although fluid transport during blastocyst formation has
been attributed to the process of simple diffusion, several studies
have indicated that the osmotic gradient across the TE layer is
relatively shallow (Borland et al., 1977; Biggers et al., 1988).
Rapid fluid flow during cavitation driven by a small osmotic
gradient suggests the existence of channel-mediated water flow
across the TE (Barcroft et al., 2003). In murine blastocysts,
aquaporin 3 and 8 are localized at the basolateral membrane
domains of the TE, while aquaporin 9 occurs within its apical
membrane domains (Barcroft et al., 2003). Treatment of
blastocysts with a mercuric compound p-chloromercuriphenyl-
sulfonic acid, an inhibitor of aquaporins, impairs the volume
recovery of murine blastocysts shrunk by exposure to a
hyperosmotic solution (Barcroft et al., 2003), supporting the
hypothesis that aquaporin mediates trans-TE water transport
during blastocyst formation.
In addition to these membrane transporters directly involved
in the accumulation of blastocoelic fluid, a permeability seal
between TE cells by tight junctions (TJs), one form of epithelial
and endothelial cell-to-cell junction, is thought to be a prere-
quisite for blastocyst formation. If the TJ seal is insufficient,
transported materials might easily leak back through the para-
cellular space and expansion of the blastocoel cavity would
never occur. TJs circumscribe individual cells as belts to seal the
intercellular space of adjacent cells and create permeability
barriers by restricting the diffusion of solutes through the
paracellular pathway (Tsukita et al., 2001; Schneeberger and
Lynch, 2004; Van Itallie and Anderson, 2005). TJs are com-
plexes composed of integral membrane proteins and peripheral
membrane proteins. Occludin, claudins, tricellulin, and JAM
family members have all been identified as TJ-associated in-
tegral membrane proteins (Furuse et al., 1993, 1998a; Ikenouchiet al., 2005; Martin-Padura et al., 1998). Among these, claudins
play central roles in the architecture and barrier function of TJs.
Claudins, 22–33 kDa in size, are predicted to have four
transmembrane domains and comprise a multi-gene family with
24 members in mice and humans (Morita et al., 1999a;Wilcox et
al., 2001). Claudins constitute the backbone structure of TJs, not
only by associating with each other as adhesion molecules
between adjacent cells, but also by polymerizing into fibril-like
structures in the plasma membrane, so-called TJ strands, which
circumscribe cells as permeability seals (Furuse et al., 1998b). In
most cell types, multiple claudin types are co-expressed in
individual cells forming TJ strands as a mosaic of different
claudins (Furuse et al., 1999). Furthermore, the combination and
mixing ratio of claudin types differ among types of epithelial or
endothelial cells, and accumulating evidence has established a
concept that heterogeneity in claudin content creates functional
diversity in the barrier property of TJs, such as conductance and
charge selectivity, depending on the physiological requirements
of cell types (Van Itallie and Anderson, 2005; Furuse and
Tsukita, 2006). Various claudin family genes have been disrupt-
ed in mice, and these mice exhibited dysfunction of epithelial or
endothelial barriers, including the epidermal barrier (Furuse et
al., 2002), blood–brain barrier (Nitta et al., 2003), blood–testis
barrier (Gow et al., 1999), cochlear barrier (Ben-Yosef et al.,
2003; Kitajiri et al., 2004), myelin barrier (Gow et al., 1999;
Miyamoto et al., 2005), and others. Furthermore, recent posi-
tional cloning studies have identified mutations of the genes
encoding tight junction proteins in several human hereditary
diseases (Simon et al., 1999; Wilcox et al., 2001; Hadj-Rabia et
al., 2004; Riazuddin et al., 2006). These studies not only indicate
that claudins play crucial roles in epithelial and endothelial
barriers in vivo, but also imply that claudins are specific targets
through which the barrier function of TJs can be modified.
The differentiation of TJs in the TE during mouse preim-
plantation embryogenesis has been reported in detail by thin-
section and freeze-fracture replica electron microscopy (Duci-
bella and Anderson, 1975; Ducibella et al., 1975; Magnuson et
al., 1977; Sheth et al., 2000). Furthermore, Fleming and collea-
gues have intensively analyzed the assembly of various TJ-
associated proteins, including two alternatively spliced forms of
ZO-1, as well as cingulin, occludin, and JAM, by immuno-
fluorescence microscopy (reviewed in Fleming et al., 2000;
Thomas et al., 2004). These studies have revealed that TJs
emerge at around the late morula stage and are mature by the 32
cell stage of blastocyst formation. However, to date, there has
been no experimental evidence that directly demonstrates the
function of TJs in blastocyst formation.
In this study, we investigated the role of the barrier function
of TJs in the TE during blastocyst formation in mouse early
embryogenesis. To modulate the barrier function of TJs, we
used the C-terminal half of Clostridium perfringens enterotoxin
(C-CPE), which binds to the extracellular domain of some
claudin family members including claudin 3, 4, 6, 7, 8, and 14
(Sonoda et al., 1999; Fujita et al., 2000). We examined the
expression of claudins in the mouse TE and confirmed that a
glutathione S-transferase fusion protein with C-CPE (GST-C-
CPE) bound to claudin 4 and 6 among TE-associated claudins.
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bryos normally developed to compact morulae, but blastocyst
expansion was inhibited, which is accompanied by the removal
of claudin 4 and 6 from TJs in the TE, and disruption of its
barrier function. These findings indicate for the first time that
the barrier function of TJs in the TE is required for normal
blastocyst formation. This study also suggests an involvement
of the barrier function of TJs in the morphogenetic events
caused by hydrostatic pressure during developmental processes.
Materials and methods
Antibodies
Rat anti-mouse occludin monoclonal antibody (mAb) (MOC37) and rabbit
anti-mouse claudin 6 polyclonal antibodies (pAb) were raised and characterized
as described previously (Saitou et al., 1997; Morita et al., 1999b). Mouse anti-
HA-tag mAb (12CA5), mouse anti-human claudin 4 mAb (3E2C1), mouse anti-
human Oct3/4 mAb (C-10), mouse anti-human Cdx2 mAb, and mouse anti-
human Na+/K+-ATPase α1 subunit mAb (C464.6) were purchased from
Boehringer Mannheim (Indianapolis, IN, USA), Zymed Labs (San Francisco,
CA, USA), BioGenex Inc. (San Ramon, CA, USA), Santa Cruz (San Francisco,
CA, USA), and Upstate Biotechnology (Lake Placid, NY, USA), respectively.
Rabbit anti-mouse Cdx2 pAb, rabbit anti-mouse Nanog pAb, rabbit anti-
aquaporin 3 pAb, rabbit anti-CPE pAb, and rabbit anti-mouse claudin 12 pAb
(Fujita et al., 2006) were kindly provided by Drs. Taketo M. M. (Kyoto
University, Japan), Yamanaka S. (Kyoto University, Japan), Takata K. (Gunma
University, Japan), Y. Horiguchi (Osaka University, Japan), and H. Chiba
(Sapporo Medical University School of Medicine, Japan), respectively. To
produce rabbit anti-mouse claudin 7 pAb, the peptide CKAAYRAPR-
SYPKSNSSKEYV, corresponding to the C-terminal cytoplasmic domain of
mouse claudin 7, was synthesized and coupled via cysteine to keyhole limpet
hemocyanin. This conjugated peptide was used as an antigen to generate pAb in
rabbits. The antiserum was affinity purified using a glutathione S-transferase
(GST) fusion protein with the C-terminal cytoplasmic domain of claudin 7. The
specificities of anti-claudin 4, 6, and 7 antibodies were confirmed by
immunoblotting of the GST fusion proteins of the C-terminal cytoplasmic
regions of claudins 1–24 and by immunofluorescence staining of mouse L
fibroblasts transiently expressing claudin types (Fig. S1).
Embryo collection and culture
To obtain enough embryos that are synchronized at each developmental
stage for immunostaining experiments with various antibodies, we generated
embryos by in vitro fertilization (IVF) rather than flushing in vivo-derived
embryos from the oviducts. C57BL/6J 9- to 11-week-old female mice were
superovulated by intraperitoneal injection of 6.7 IU Pregnant Mare Serum go-
nadotrophin (PMS; Teikoku Zouki, Japan) followed 56 h later by intraperitoneal
injection of 6.7 IU human chorionic gonadotrophin (hCG; Teikoku Zouki,
Japan). After a further 15 h, oocytes were collected from unmated mice and
fertilized in Human Tubal Fluid (HTF) medium containing 0.4% of bovine
serum albumin (BSA; Sigma) by IVF. IVF embryos were cultured in modified
Whitten’s medium (110 mM NaCl, 4.78 mM KCl, 1.19 mMMgSO4·7H2O, 22.
6 mM NaHCO3, 5.56 mM glucose, 0.226 mM sodium pyruvate, 1.50 mM
calcium lactate, 2 μM 2-mercaptoethanol, 50 μM EDTA·2Na) containing 0.3%
of BSA, F-V (Nacalai Tesque, Japan) in 5% CO2 at 37 °C. For GST-C-CPE or
GST-C-CPE313 treatment, these proteins were added to the culture medium at
100 μg/ml. The culture medium was changed to fresh medium every 24 h.
Production of GST-C-CPE fusion proteins
DNA fragments encoding the C-terminal half of CPE (aa 184–319) and its
deletion mutant (aa 184–313) were amplified from the template plasmid DNA
containing the full length of CPE (kindly provided by Dr. Y. Horiguchi) using
primer pairs 5′-cgcggatccAGATGTGTTTTAACAGTTCCA-3′/5′-gggctcgagT-TAAAATTTTTGAAATAATAT-3′ and 5′-gaattcAGATGTGTTTTAACAGTT-
CCATC-3′/5′-gaattcTCATGAATAAGGGTAATTTCCACT-3′, respectively,
and subcloned into pGEX6P-1 vector (Amersham Pharmacia Biotech,
Buckinghamshire, UK). The obtained fusion protein products were designated
GST-C-CPE and GST-C-CPE313, respectively. These GST fusion proteins were
generated in E. coli and purified using glutathione–Sepharose 4B beads (Amer-
sham Pharmacia Biotech). Eluted GST fusion proteins were dialyzed against
PBS at 4 °C and used for experiments.
RNA isolation and RT-PCR
Total RNAwas isolated from E4.0-stage embryos using an RNeasy micro kit
(QIAGEN). RNA was reverse transcribed using Superscript II reverse trans-
criptase, according to the manufacturer’s instructions (Invitrogen), and the first-
strand cDNA (0.25 embryo/sample) or 6×104 copy of plasmid DNA containing
each claudin cDNAwas amplified by PCR using specific primers for each claudin.
Amplified DNA fragments were analyzed by agarose gel electrophoresis. The
primers used for RT-PCR are shown in Table 1. The amplification reaction was
performed using step-down PCR as follows: 3 cycles; 95 °C for 30 s, 69 °C for 30
s, 72 °C for 60 s, 3 cycles; 95 °C for 30 s, 66 °C for 30 s, 72 °C for 60 s, 3 cycles;
95 °C for 30 s, 63 °C for 30 s, 72 °C for 60 s, 3 cycles; 95 °C for 30 s, 60 °C for 30
s, 72 °C for 60 s, 25 cycles; 95 °C for 30 s, 57 °C for 30 s, 72 °C for 60 s.
Binding assay of GST-C-CPEs
GST-C-CPE binding activity to claudins was detected by flow cytometry as
follows. Briefly, HEK293 cells transiently transfected with claudin genes were
dissociated into single cells and incubated with culture medium containing GST-
C-CPEs (20 μg/ml) for 15 min on ice. Cells were then washed twice with PBS
containing 0.1% BSA and stained with an anti-CPE pAb followed by Alexa
Flour 488-labeled anti-rabbit IgG (Molecular Probes). GST-C-CPE binding to
cells was evaluated using an EPICS flow cytometer (Beckman Coulter).
Immunofluorescence microscopy and functional barrier assay
Embryos cultured in the presence or absence of GST-C-CPEs were fixed
with 3.7% formaldehyde for 20 min at room temperature (for labeling of Cdx2
and Oct3/4) or cold 10% trichloroacetic acid (TCA) for 15 min on ice (for the
others). Embryos were then washed twice with 0.1% TritonX-100 in PBS and
permeabilized in 0.1% TritonX-100 in PBS for 10 min at room temperature.
After blocking with 3% BSA in PBS, they were incubated in antigen-specific
antibody at 4 °C overnight, washed as described above, and incubated in
fluorescence-conjugated secondary antibody for 1 h at room temperature.
Stained embryos were examined using a Zeiss LSM510META confocal laser
scanning microscope (Zeiss).
To examine the barrier function of the TE, embryos treated with GST-C-CPE
or GST-C-CPE313 were incubated in mWMmedium containing 1 mg/ml FITC-
dextran (4.4 kDa) (Sigma) for 10 min and observed immediately using a Zeiss
LSM510META confocal laser scanning microscope (Zeiss).
Measurement of cell number and diameter of embryos
Embryos were fixed with 3.7% formaldehyde for 20min at room temperature
and cell nuclei were visualized with DAPI. These embryos were observed along
the Z-axis every 2 μm using a DeltaVision microscope (Applied Precision) and
the total number of cells in these embryos was counted. Measurement of the
embryos’ diameters was performed using phase-contrast microscopy.Results
Expression of claudin family members during mouse blastocyst
formation
The mouse claudin family consists of at least 24 genes, each
of which has a unique tissue expression pattern, but little is
Table 1
Primers used in RT-PCR analysis of claudin family gene expression in mouse embryos
Gene Primer sequence (5′→3′)
Forward Reverse
Cldn1 CTGCAGCTGCTGGGTTTCATCCT CACTAGAAGGTGTTGGCTTGGGATAAGG
Cldn2 TGGGCTACATCCTAGGCCTTTTGGG TCACACATACCCAGTCAGGCTGTATGAGTT
Cldn3 ATGTCCATGGGCCTGGAGAT TCAGACGTAGTCCTTGCGGT
Cldn4 ATGGCGTCTATGGGACTACAGGTCC CCGAGTAGGGCTTGTCGTTGCTAC
Cldn5 ATGGGGTCTGCAGCGTTGGA TGTCGTAATCGCCATTGGCC
Cldn6 ATGGCCTCTACTGGTCTGCA TCACACATAATTCTTGGTGGGA
Cldn7 CCTGATAGCGAGCACTGCCATC TGCTCGGTACGCAGCTTTGC
Cldn8 CTGTCAGCTGGGTTGCCAAT TTCGGCGTGGAAACTCCGTT
Cldn9 ATGGCTTCCACTGGCCTTGAATTCTT TCACACATAGTCCCTCTTATCCAGTCCC
Cldn10 CCAGGCATGTAGAGGACTAATGATCGCT TCTCCTTCTCCGCCTTGATACTTGGTC
Cldn11 ATGGTAGCCACTTGCCTTCA GTTGGCGAGCTGGAACCAGAAGAG
Cldn12 TAACTGGAGGAAACTGCGGC CCCCTGAGCTAGCAATAGTG
Cldn13 ATGGTCGTCAGCAAACAAGAGGC TGGCTCCTGAAGGTCTAGCACTAGGG
Cldn14 CAGCGGTCCAGCTCCTAGGCTTC TCACACGTAGTCATTCAGCCTGTACCC
Cldn15 CAACACCATCTTTGAGAACCTGTGG AGCAGGTGGAGAAGACACAGATGC
Cldn16 GTGAAAGACTGGGCACTATCATC GAACACAGATTAACATTGGGCAG
Cldn17 CTGAAGCAGTAGGCCAAGGAA CATAAGCCAGGGACTGATGTTG
Cldn18 CAGCCATGCTGCAAGCTGTACGA TTGCTGTCATCTGGTGTCAGGCC
Cldn19 GCCTCCAGCTCCTGGGCTACTTC TCAGACGTACTCTCTGGCAGCAGTTGA
Cldn20 GGAGAACAGAAGAGTAACATCATGG CACTACCTGTTCATCCCACAGC
Cldn21 ATGGCTTTCATCTTCAGAACGGC GTATGAACCATGATCTCGAGGTCCC
Cldn22 ATGGGCTTAGTCTTCCGAACGGC GATTTCTGGATTGGCTTGCTTCAGC
Cldn23 CGGGTTGCTGCTTAATCTTGTCAGTACAC CCAGCACCAGACTGTAGCTGACCTG
Cldn24 ATGGCCTGTAGCTTCCGTGGGAG CTAGATGACCTGGTTCACCGGTCTTG
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TE. To determine which claudins are expressed in the mouse
early embryo, we analyzed transcripts isolated from several
embryonic stages by RT-PCR.We found that claudin 4, 6, 7, and
12 were expressed at the precompact 8-cell stage (data not
shown) and the blastocyst stage (E4.0) (Fig. 1A). Protein
expression of these claudins in mouse early embryos was
confirmed by double immunofluorescence staining using
antibodies to these claudins and occludin, whose concentration
is a good marker for TJ formation. In the compact 8-cell stage,
punctate staining of claudins and occludin was sometimes
observed along the cell–cell contact region (Fig. S2). By
contrast, at the 16-cell stage, a continuous band of claudin 4, 6,
and 7, and occludin around blastomeres was clearly observed
(Fig. S2). In blastocysts at E4.0, claudin 4, 6, and 7 were
concentrated continuously at the most apical region of cell–cell
contact planes in TEs co-localizing with occludin (Fig. 1B), but
no signal for these proteins was detected in the ICM. During
these stages, there was no significant difference in the timing of
their appearance into TJs among claudin 4, 6, and 7 (data not
shown). Although the expression of claudin 12 mRNA was
confirmed in RT-PCR (Fig. 1A), the concentration of claudin 12
protein into TJs was not detected in immunofluorescence
staining during these stages (data not shown). These results
indicate that at least claudin 4, 6, and 7 constitute TJs in the TE
during mouse blastocyst formation.
Binding of GST-C-CPE fusion protein to mouse claudin 4 and 6
Originally, claudin 3 and 4 were identified as the cellular
receptors for CPE, C. perfringens enterotoxin (Katahira et al.,1997a,b). CPE protein is divided into two domains: the NH2-
terminal half with cytotoxicity and the C-terminal half with cell-
binding activity. A recombinant C-terminal half of CPE (aa
184–319 of CPE; C-CPE) binds to these claudins without
affecting cell viability (Katahira et al., 1997a). We have
previously shown that CPE binds to some claudin family
members in addition to claudin 3 and 4 and that C-CPE hampers
TJ formation in MDCK cells through down-regulation of
claudin 4, thereby reducing the barrier function of the cellular
sheet (Sonoda et al., 1999). Our aim in this study was to disturb
the function of TJs during mouse blastocyst formation, in vitro,
by treatment with C-CPE. However, recombinant C-CPE
tended to form aggregates, which made it difficult to control
its concentration in solution in these experiments. Thus, we
generated a recombinant GST-C-CPE fusion protein, which was
highly soluble and did not aggregate during longer storage, and
used it in further experiments. To examine whether or not GST-
C-CPE binds to claudins that are expressed in the TE, claudin 4,
6, or 7 was transiently expressed in HEK293 cells, and the
binding of GST-C-CPE to the surface of these cells was
analyzed by immunofluorescence staining with an anti-CPE
pAb. As shown in Fig. 2A, exogenous claudins were localized
at the plasma membrane as well as the intracellular membrane
compartments, and FACS analyses revealed that GST-C-CPE
bound to HEK293 cells expressing claudin 4 and 6, but not to
those expressing claudin 7 (Fig. 2B), indicating that GST-C-
CPE binds to claudin 4 and 6. GST-C-CPE did not bind to
claudin 12, whose expression in the blastocyst was detected in
RT-PCR but not in immunofluorescence microscopy (Fig. 1A)
in the same assay (data not shown). The lack of GST-C-CPE
binding to claudin 7 was inconsistent with our previous ob-
Fig. 1. Expression of claudins in mouse blastocysts. (A) RNA extracted from E4.0-stage mouse embryos was reverse transcribed and analyzed by PCR using specific
primers for each claudin. DNA bands of claudin 4, 6, 7, and 12 were detected on agarose gel electrophoresis (RT+). No band was detected from RNA samples without
the reverse transcriptase (RT−). In the same PCR condition, enough amounts of the DNA fragments of respective claudins were amplified from the template containing
6×104 copy of each claudin cDNA (cont). (B) Immunolocalization of claudin 4, 6, and 7 in E4.0 mouse embryos. Embryos were fixed and processed for single
immunofluorescence staining of each claudin (a, e, and i) in a surface view or for double staining using antibodies for each claudin (b, f, and j) and occludin (c, g, and k)
in an equatorial section. Specimens were analyzed by confocal microscopy. Panels d, h, and l are the merged images of each claudin and occludin. Scale bar, 20 μm.
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claudin 7 on the cell surface (Fujita et al., 2000). However, we
confirmed that HEK293 cells overexpressing claudin 7 were
also sensitive to full-length CPE (data not shown), indicating
that full-length CPE could bind to claudin 7. The reason for this
discrepancy is not clear, but one possible explanation is that the
structural difference in the claudin-binding domains between
full-length CPE and GST-C-CPE resulted in the difference in
the compatibility of these peptides with claudin 7.
The receptor-binding domain of CPE has been reported to
locate at the C-terminal region of this protein (Hanna et al.,
1991). Consistent with this notion, a GST-C-CPE mutant in
which the C-terminal six amino acids were deleted (GST-C-
CPE313) did not bind to HEK293 cells overexpressing claudin
4 or 6 in the same assay (Fig. 2B). Therefore, we used GST-C-
CPE313 as a negative control for GST-C-CPE, in terms of
claudin binding, in further analyses.
Inhibition of blastocyst formation in GST-C-CPE-treated embryos
In normal embryos, compaction of 8-cell blastomeres oc-
curred at E2.5. The blastocoel cavity then became clearly visibleat E3.5, and it continued to expand accompanied by flattening
of the TE cells throughout blastocyst formation. To disturb the
normal functions of TJs during mouse blastocyst formation,
mouse early embryos were cultured from the 4-cell stage in
vitro in the presence of GST-C-CPE or GST-C-CPE313, and
their morphology was examined by phase-contrast microscopy
(Fig. 3A). Prior to the analysis, we confirmed that GST-C-CPE
and GST-C-CPE313, each with a molecular mass of ∼43 kDa,
easily penetrated the zona pellucida and reached blastomeres
when embryos were incubated in culture medium containing
these recombinant proteins (Fig. S3A). Embryos treated with
GST-C-CPE313 as a negative control showed normal develop-
ment in vitro throughout the culture period, similar to those with
no treatment. By contrast, GST-C-CPE-treated embryos devel-
oped normally to compact morulae but failed to form a normal
blastocyst. At E3.5, most GST-C-CPE-treated embryos had an
undetectable or a very small blastocoel cavity. At E4.0, most
embryos (96.4±3.4%, n=126) had an immature blastocoel
cavity and blastomeres had a rounded shape, although cell
division appeared to proceed normally. The remaining embryos
had an obvious blastocoel cavity, with flattened blastomeres
(Fig. 3B), but these embryos never exhibited expansion and the
Fig. 2. Binding of GST-C-CPE to claudins. (A) HEK293 cells transiently expressing HA-tagged claudin 4, 6, and 7 were stained with an anti-HA mAb. Exogenous
claudins were localized at cell surface as well as intracellular membrane compartments. (B) HEK293 cells expressing each claudin were dissociated and incubated with
GST-C-CPE or GST-C-CPE313. Cells were then fluorescently labeled with anti-CPE pAb and analyzed using a flow cytometer. GST-C-CPE bound to HEK293 cells
expressing claudin 4 and 6 (arrows), but not to those expressing claudin 7. The binding of GST-C-CPE313, which is a deletion mutant of GST-C-CPE missing the C-
terminal six amino acids, to these cells was not detected.
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GST-C-CPE313-treated embryos. We designated these embryo
types with rounded and flattened blastomeres at E4.0 as type I
and type II embryos, respectively (Figs. 3A, B). We also
designated outer blastomeres in GST-C-CPE-treated embryos at
the blastocyst stage as TE-like cells in this study.
The average cell number of GST-C-CPE-treated embryos
reaching E4.0 was slightly less than that of control embryos
reaching this stage (50.0±6.87 vs 44.3±7.35), indicating that
GST-C-CPE treatment slightly reduced cell growth (Table 2).
However, the failure of normal blastocyst formation induced by
GST-C-CPE treatment was not likely to be due to retardation of
cell growth because even GST-C-CPE-treated embryos with
over 50 cells at E4.0 failed to exhibit expansion of theFig. 3. Effects of GST-C-CPE on blastocyst formation in cultured mouse preimplanta
C-CPE or GST-C-CPE313 (100 μg/ml each) from the 4-cell stage, and their morpho
Embryos with no treatment and those treated with GST-C-CPE313 exhibited compac
CPE-treated embryos developed to compact morulae at E2.75 but failed to form a nor
and an immature blastocoel cavity. GST-C-CPE-treated embryos at E4.0 could be c
blastomeres and undetectable or very small blastocoel. Type II embryos had smoot
Arrowheads indicate the boundary of blastocoel cavity. (B) The proportion of type I
respectively. (C) GST-C-CPE was added to the culture medium at the indicated emb
microscopy. Embryos incubated with GST-C-CPE added at E3.0 failed to form a norm
observed until E5.5 (upper panel). By contrast, embryos incubated with GST-C-CP
expansion (lower panel). (D) GST-C-CPE was added to the culture medium from
expanded blastocoel (E3.75) and hatched at E5.5. Scale bar, 20 μm.blastocoel cavity although most control embryos with less than
50 cells showed blastocoel expansion at the same stage (data not
shown). To exclude the influence of cell growth retardation in
interpreting these data, the data were collected from GST-C-
CPE-treated and GST-C-CPE313-treated groups of embryos
with a cell number of 41–50 at E4.0, and the diameters of the
embryos were compared. As shown in Table 2, the diameter of
GST-C-CPE-treated embryos was significantly less than that of
control embryos, although the cell number was almost equal
between these two groups, indicating that GST-C-CPE inhibited
blastocyst formation in mouse embryos.
We then examined the critical point of GST-C-CPE action
during blastocyst formation (Fig. 3C). When GST-C-CPE was
added to the culture medium at E3.0, embryos could not form ation embryos. (A) IVF-derived embryos were incubated in the presence of GST-
logy at each developmental stage was examined by phase-contrast microscopy.
tion at E2.75; blastocoel cavities became obvious at E3.5. By contrast, GST-C-
mal blastocyst at E3.5 and later stages. These embryos had rounded blastomeres
lassified into two populations: type I and type II. Type I embryos had rounded
h TE-like cells and an obvious blastocoel, but this never exhibited expansion.
and type II GST-C-CPE-treated embryos was 96.4% to 3.6% (±3.4%, n=126),
ryonic stage and the morphology of embryos was examined by phase–contrast
al blastocyst. They had rounded blastomeres and blastocoel expansion was never
E added at E3.5 developed normally in further culture and showed blastocoel
the 4-cell stage and removed at E3.5. The embryos quickly formed a normal
515K. Moriwaki et al. / Developmental Biology 312 (2007) 509–522normal blastocoel cavity, and the size of embryos remained
constant without expansion by E5.5. By contrast, when GST-C-
CPE was added to the culture medium at E3.5, blastocyst
formation was not affected although GST-C-CPE easily
penetrates the zona pellucida and reaches the surface of
blastomeres (Fig. S3B), and embryos hatched at E5.5 like
those without treatment. These results show that around E3.5 isthe critical point for the action of C-CPE added to the culture
medium. When GST-C-CPE added from the 4-cell stage was
removed at E3.5, blastocyst formation, which was once
retarded, resumed; the embryos formed normal blastocoel
cavities at E3.75 and finally hatched at E5.5 (Fig. 3D). This
quick recovery of blastocyst expansion after removal of GST-C-
CPE also supports our conclusion that the failure of blastocyst
Table 2
Cell number and diameter of E4.0-stage embryos treated with GST-C-CPE or
GST-C-CPE313 (control)
No. of embryos
examined
Cell number
in embryoa
Diameter of
embryo (μm)a
Total embryos at E4.0 stage
Control 42 50.0±6.87 86.9±5.42
GST-C-CPE 40 44.3±7.35b 69.1±5.70c
Embryos with 41–50 cells at E4.0 stage
Control 18 45.4±2.52 85.3±5.48
GST-C-CPE 18 45.0±2.43 69.5±5.09c
aValues are means±SD. bpb0.001, cp≪0.001.
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because of the retardation of cell growth.
Disruption of the barrier function of the TE-like cells in
GST-C-CPE-treated embryos
Next, we investigated the barrier function of the TE-like cells
in embryos treated with GST-C-CPE. In vitro-cultured embryos
at various embryonic stages were incubated in medium con-
taining FITC-dextran of 4.4 kDa for 10 min and the influx of
FITC-dextran into the blastocoel cavity was examined by
confocal laser scanning fluorescence microscopy. In normal
embryos without any treatment, tracer influx occurred at E3.0
but became undetectable at E3.5, showing that the barrier
function of TJs in the TE to this tracer was established at around
E3.5 (Fig. 4A). However, in GST-C-CPE-treated embryos,
FITC-dextran of 4.4 kDa infiltrated into the blastocoel cavity
even at E4.0, indicating that the barrier function of the outer
blastomeres was hampered by GST-C-CPE (Fig. 4B). GST-C-
CPE313 did not affect the barrier function of the TE. These
results indicate that dysfunction of the barrier function of TJs in
the TE is most likely participate in the inhibition of blastocyst
formation in GST-C-CPE-treated mouse early embryo.
Subcellular localization of claudins, occludin,
Na+/K+-ATPase, and aquaporin in TE-like cells in
GST-C-CPE-treated embryos
To understand the molecular mechanism underlying the
inhibition of blastocyst formation caused by the GST-C-CPE
treatment, we next examined the subcellular localization of
claudins and occludin expressed in the TE-like cells of GST-C-
CPE-treated embryos by immunofluorescence confocal micro-
scopy (Fig. 5). In E4.0 embryos cultured in the presence of
GST-C-CPE from the 4-cell stage, occludin was normally
localized at cell–cell junctions delineating the TE-like cells.
Claudin 7, which does not bind to GST-C-CPE, also showed
normal distribution at TJs. By contrast, localization of claudin 4
and 6, which do bind to GST-C-CPE, were severely affected.
They exhibited diffuse localization in the plasma membrane and
the cytoplasm, and the concentrations of these claudins in cell–
cell junctions often disappeared, even though occludin staining
remained normal (Fig. 5). Abnormal localizations of claudin 4
and 6 were never observed in embryos incubated with GST-C-CPE313 (data not shown). These results suggest that TJs of the
TE are partially disturbed in GST-C-CPE-treated embryos
because of the loss of claudin 4 and 6 from TJs.
Previous studies have indicated that Na+/K+-ATPases and
aquaporin water channels within the plasma membrane of the
TE are involved in blastocoel cavity formation (Watson et al.,
2004). To exclude the possibility that GST-C-CPE affects these
transporters, we examined their expression and localization by
immunofluorescence staining. In control embryos, both the
Na+/K+-ATPase α1 subunit and aquaporin 3 were localized at
the basolateral plasma membrane of the TE of E4.0 embryos
(Figs. 6A, B). In GST-C-CPE-treated embryos, these transpor-
ters were localized at the basolateral plasma membrane of the
outer cells (TE-like cells), similar to those in control embryos,
although these cells showed a rounded shape (Figs. 6A, B). This
suggests that the molecular targets of the GST-C-CPE action are
claudins, not Na+/K+-ATPases or aquaporin water channels.
Effect of GST-C-CPE treatment on cell differentiation in
blastocysts
GST-C-CPE treatment disrupted the barrier function of the
TE, indicating that the solution environment of the blastocoelic
fluid was also affected in these embryos. Abnormal blastocoelic
fluid may influence cell fate and differentiation in blastocysts.
To address this issue, we examined the expression of Oct3/4 and
Cdx2, which are markers of pluripotency and TE differentia-
tion, respectively (Fig. 7). In normal cultured embryos, Oct3/4
expression was initially observed in all blastomeres (data not
shown). It was down-regulated in the Cdx2-positive TE lineage
during the early blastocyst stage and became restricted to the
ICM by E4.0 (Fig. 7A), as described previously (Stumpf et al.,
2005; Niwa et al., 2005). By contrast, in GST-C-CPE-treated
embryos with a blastocoel cavity, although Cdx2 was normally
expressed in the outer blastomeres (TE-like cells), Oct3/4 was
expressed in all cells, including the outer cells, at E4.0 (Figs.
7B, C). However, at E5.5, Oct3/4 could not be detected in the
Cdx2-positive blastomeres of the GST-C-CPE-treated embryos
(Fig. 7D). These results indicate that the disruption of the barrier
function of the TE causes the significant developmental delay of
blastocysts, although it does not affect the final differentiation
of the TE itself and the ICM in terms of the expression of Cdx2
and Oct3/4.
Discussion
Accumulating evidence has revealed that claudin family of
membrane proteins plays key roles in the structure and function
of TJs, implying that claudins are good targets through which to
modify the barrier function of TJs by a molecular biological
approach. Here, we found that TJs in the mouse TE consist of
claudin 4, 6, and 7 at least, among which claudin 4 and 6 bind to
GST-C-CPE, a claudin inhibitory polypeptide. Using IVF-
derived mouse early embryos, we demonstrated that the cavi-
tation of the blastocoel was perturbed by GST-C-CPE treatment,
accompanied by dysfunction of the TJ barrier of the TE and loss
of claudin 4 and 6 from TJs. These findings demonstrate for the
Fig. 4. Effects of GST-C-CPE on the barrier function of the TE. (A) Normal cultured embryos at E3.0, E3.25, and E3.5 incubated in medium containing FITC-dextran
(4.4 kDa) for 10 min were examined by confocal microscopy and phase-contrast microscopy (lower and upper panels, respectively). In embryos at E3.25, intense
fluorescent signal of FITC-dextran was observed in the blastocoel as well as in the culture medium surrounding embryos, indicating the influx of FITC-dextran into the
blastocoel (E3.25 in upper panels) from the medium. By contrast, at E3.5, slight penetration of FITC-dextran into the blastocoel was observed in some embryos but not
others (E3.5, left and right, respectively, in upper panels), suggesting that the TE barrier was established around this stage. (B) The influx of FITC-dextran was
compared between GST-C-CPE-treated and GST-C-CPE313-treated embryos at E4.0. In GST-C-CPE313-treated embryos, the influx of FITC-dextran was hardly
detected at E4.0. By contrast, obvious penetration of FITC-dextran into the blastocoel was observed even at E4.0, not only in GST-C-CPE-treated type I embryos,
which had rounded blastomeres and an undetectable or very small blastocoel, but also in GST-C-CPE-treated type II embryos, which had smooth blastomeres and an
immature blastocoel. Scale bars, 20 μm.
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normal blastocyst formation. This study also suggests that the
barrier function of TJs is indeed involved in the morphogenetic
events caused by hydrostatic pressure during developmental
processes.
We previously reported that C-CPE can be utilized as an
inhibitor of TJ formation. C-CPE directly binds to the second
extracellular loop of some claudin family members, including
claudin 4, which was originally identified as a cellular receptor
of CPE (Katahira et al., 1997a). When C-CPE was added to
MDCK I cells expressing at least claudin 1 and 4, claudin 4 was
down-regulated from TJs accompanied by disorganization of TJ
strands and a remarkable reduction in the barrier function of the
cellular sheet (Sonoda et al., 1999). In the present study, we
generated a GST-C-CPE fusion protein to use as a claudin in-hibitor. The action of GST-C-CPE seemed to be very specific to
the susceptible claudins, whose localizations at TJs were mark-
edly affected by GST-C-CPE treatment with disruption of the TJ
barrier. In addition, GST-C-CPE313, which is a six amino acid
deletion construct of C-CPE, appeared not to influence blas-
tocyst formation. These results confirmed the suitability of
GST-C-CPE as a specific inhibitor to the barrier function of TJs.
Furthermore, the expression and basolateral localization of the
Na+/K+-ATPase α1 subunit and aquaporin 3, which are be-
lieved to be involved in blastocyst formation, were not affected
by GST-C-CPE treatment. This observation suggested that the
apico-basal polarity of the TE was maintained in GST-C-CPE-
treated embryos and that other subtypes of Na+/K+-ATPase
subunits and aquaporins expressed in the TE also show normal
localization on plasma membrane domains. Considering these
Fig. 5. Immunolocalization of claudins in the TE of GST-C-CPE-treated em-
bryos. GST-C-CPE-treated E4.0-stage embryos were double-stained with pAbs
for claudin 4, 6, or 7 and anti-occludin mAb. In GST-C-CPE-treated embryos,
claudin 4 and 6 disappeared from TJs of the TE (arrowheads), but claudin 7
retained its continuous localization. Occludin concentration was not affected by
GST-C-CPE-treatment. Scale bars, 20 μm.
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directly binds to the extracellular domain of claudin 4 and 6 in
the TE and perturbs their TJ-forming activity, leading to dys-
function of the TE barrier. Claudin molecules associate with
each other between adjacent cells and concomitantly assemble
into fibril-like structures within the plasma membrane to form
TJ strands (Furuse et al., 1998b). Therefore, GST-C-CPE bind-
ing to the extracellular domain of claudin 4 and 6 may prevent
these claudins from being incorporated into TJ strands because
of steric hindrance or the conformational change in these
claudins. Alternatively, GST-C-CPE binding may induce the
down-regulation of these claudins from the plasma membrane
(Sonoda et al., 1999).
In GST-C-CPE-treated embryos, claudin 4 and 6 were not
assembled into TJs in the TE, while claudin 7 was linearly
concentrated at the most apical region of the lateral membrane
with occludin. This suggests that GST-C-CPE-treated mouse
embryos can form continuous TJs containing at least claudin 7
at the immunofluorescence staining level. It is now widely
accepted that the difference in the combination and the mixing
ratio of claudins creates functional diversity of tight junctions;
for example, in terms of conductance and charge selectivity(Van Itallie and Anderson, 2005; Furuse and Tsukita, 2006). In
this study, however, TJs in GST-C-CPE-treated blastocysts
probably had destructive breaks since even fluorescein dextran
of 4.4 kDa could easily penetrate into the paracellular space.
Similar dysfunction of the TJ barrier was observed in several
claudin gene knock-out mice. In claudin 1-deficient mice, the
barrier function of TJs in the keratinocytes of epidermis was
remarkably disrupted, and a water-soluble tracer with a
molecular mass of ∼500 Da easily penetrated these TJs (Furuse
et al., 2002). However, epidermal keratinocytes in these mice
retained TJs composed of claudin 4 at least (Furuse et al., 2002).
Claudin 5-deficient mice also showed remarkable disruption of
the barrier function of the TJs in brain endothelial cells, which
normally express at least claudin 5 (Nitta et al., 2003). In these
mice, the barrier function of TJs to a tracer with a molecular
mass of ∼800 Da was severely disrupted, leading to dys-
function of the blood–brain barrier, even though TJs were ob-
served in brain endothelial cells by ultrathin section electron
microscopy (Nitta et al., 2003). In all cases, including that of
GST-C-CPE-treated mouse blastocysts, continuous TJs appear-
ed to be formed, but their barrier functions were remarkably
disrupted. Although the molecular mechanism underlying this
discrepancy remains elusive, one possibility is that GST-C-CPE
treatment or disruption of a claudin gene may lead to a defi-
ciency in the levels of claudin molecules such that TJ strands
have partial breaks. Alternatively, the change in claudin species
in TJs may cause a change in the balance of dynamic behavior
of TJ strands (such as end-to-end or end-to-side breaking and
annealing) resulting in the acceleration of paracellular transport
of solutes (Sasaki et al., 2003). To address this issue, detailed
morphological analyses should be performed by freeze-fracture
replica electron microscopy in future studies.
Another important point is whether the separation of the
fluid compartment is required for the growth, viability, and
differentiation of cells during the developmental process. In
claudin 14 null mice, a model for human autosomal recessive
deafness, cochlear hair cells differentiate normally but
degenerate later during the first 3 weeks of life (Ben-Yosef et
al., 2003). In the organ of Corti in the inner ear in mice, claudin
14 is a component of TJs of the reticular lamina, which
separates K+-rich endolymph and Na+-rich perilymph. One
explanation for the phenotype of claudin 14-deficient mice is
that the disruption of the cochlear barrier results in the back-
flow of high K+ solution in the endolymph to the compartment
of perilymph (Ben-Yosef et al., 2003). This could lead to the
exposure of the basolateral membrane domain of hair cells to a
relatively high K+ solution, which is toxic to these cells
(Boettger et al., 2002). In this study, GST-C-CPE treatment
induced slight retardation of cell growth, but its mechanism
remains elusive. In contrast to our initial speculation, the ICM
and the TE underwent almost normal differentiation in terms of
the expression of Cdx2, a TE differentiation marker, and Oct3/
4, a pluripotency marker (Beck et al., 1995; Palmieri et al.,
1994; Mitsui et al., 2003; Stumpf et al., 2005), although down-
regulation of Oct3/4 from the outer blastomeres (TE-like cells)
was retarded. It is of interest whether further development of
the embryo is affected by GST-C-CPE treatment, but,
Fig. 6. Immunolocalization of Na+/K+-ATPase and aquaporin 3 in GST-C-CPE-treated embryos. The Na+/K+-ATPase α1 subunit (A) and aquaporin 3 (B) were
localized at the basolateral membrane of the TE in GST-C-CPE313-treated (control) blastocysts at E4.0 (arrowheads). In GST-C-CPE-treated embryos, both
transporter proteins in the blastomeres were mostly localized at the basolateral membrane (arrowheads), the lumen of the cavity, although the cells exhibited a rounded
shape without expansion. Arrows indicate occludin concentration at TJs, which separates apical and basolateral membrane domains. Scale bars, 20 μm.
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mouse embryos because of technical limitations. Application
of GST-C-CPE to other developmental systems, such as chick
or zebrafish embryos, would be useful to elucidate the role of
TJs in morphogenetic events and cell differentiation during
early development.
Kim and colleagues have reported that occludin, a trans-
membrane protein of TJs, is involved in normal blastocyst
formation (Kim et al., 2004). They cultured eight-cell embryos
and morulae in the presence of a commercial anti-occludin
antibody raised against the C-terminal cytoplasmic region and
found that this treatment inhibited blastocoel formation and
increased the permeability of the TE of nascent and expandingblastocysts to FITC-dextran of 4 kDa. It is difficult to under-
stand how this antibody acted on occludin in the TE cells of live
embryos from the culture medium. Occludin-deficient mice are
born normally (Saitou et al., 2000) and we observed that
occludin-null embryos without maternal occludin, generated by
IVF using occludin−/− eggs and occludin+/− sperm, underwent
blastocoel expansion (K. Moriwaki and M. Furuse, unpub-
lished). Therefore, further investigation is needed to clarify the
role of occludin in the barrier function of the TE during
blastocyst formation.
In summary, we have shown that blastocoel expansion
during mouse blastocyst formation was perturbed by GST-C-
CPE, a claudin inhibitory polypeptide, accompanied by
Fig. 7. Effects of GST-C-CPE on the expression of Cdx2 and Oct3/4. GST-C-CPE313 or GST-C-CPE-treated embryos were double-stained with anti-Oct3/4 mAb and
anti-Cdx2 antibody and examined by confocal laser scanning microscopy. In control E4.0 embryos treated with GST-C-CPE313, although Cdx2, a TE differentiation
marker, (green) was normally expressed in the outer blastomeres (TE-like cells), Oct3/4 (red), a pluripotency marker, was down-regulated in the Cdx2-positive TE-like
cells (A). However, in GST-C-CPE-treated embryos at E4.0, the expression of Oct3/4 was retained in the outer blastomeres with Cdx2 (B, C). By E5.5, Oct3/4
expression was down-regulated in the outer blastomeres of GST-C-CPE-treated embryos (D). Scale bars, 20 μm.
520 K. Moriwaki et al. / Developmental Biology 312 (2007) 509–522dysfunction of the TJ barrier of the TE and loss of claudin 4 and
6 from TJs. This study for the first time demonstrates that the
barrier function of TJs in the TE is required for normal blas-
tocyst formation. Future applications of GST-C-CPE to various
experimental systems would clarify the role of TJs during
developmental processes.
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